XML 37 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
Dec. 31, 2014
Mar. 31, 2014
Current assets    
Cash $ 2,775,735us-gaap_Cash $ 1,250,279us-gaap_Cash
Accounts receivable 15,226us-gaap_AccountsReceivableNetCurrent 95,177us-gaap_AccountsReceivableNetCurrent
Deferred financing costs 131,489us-gaap_DeferredFinanceCostsNet 83,191us-gaap_DeferredFinanceCostsNet
Prepaid expenses and other current assets 46,754us-gaap_PrepaidExpenseAndOtherAssets 50,699us-gaap_PrepaidExpenseAndOtherAssets
Total current assets 2,969,204us-gaap_AssetsCurrent 1,479,346us-gaap_AssetsCurrent
Property and equipment, net 63,138us-gaap_PropertyPlantAndEquipmentNet 84,279us-gaap_PropertyPlantAndEquipmentNet
Patents and patents pending, net 105,616us-gaap_IntangibleAssetsNetExcludingGoodwill 112,489us-gaap_IntangibleAssetsNetExcludingGoodwill
Deposits 18,537us-gaap_DepositsAssets 18,988us-gaap_DepositsAssets
Total assets 3,156,495us-gaap_Assets 1,695,102us-gaap_Assets
Current liabilities    
Accounts payable 324,337us-gaap_AccountsPayableCurrent 517,651us-gaap_AccountsPayableCurrent
Accrued expenses 440,419us-gaap_AccruedLiabilitiesCurrent 1,855,374us-gaap_AccruedLiabilitiesCurrent
Due to related parties 810,381us-gaap_DueToRelatedPartiesCurrent 839,070us-gaap_DueToRelatedPartiesCurrent
Notes payable 22,500us-gaap_NotesPayableCurrent 390,000us-gaap_NotesPayableCurrent
Convertible notes payable, current portion 0us-gaap_ConvertibleNotesPayableCurrent 1,367,655us-gaap_ConvertibleNotesPayableCurrent
Derivative liabilities 0us-gaap_DerivativeLiabilitiesCurrent 10,679,067us-gaap_DerivativeLiabilitiesCurrent
Total current liabilities 1,597,637us-gaap_LiabilitiesCurrent 15,648,817us-gaap_LiabilitiesCurrent
Noncurrent liabilities    
Convertible notes payable, noncurrent portion 264,252us-gaap_ConvertibleLongTermNotesPayable 776,451us-gaap_ConvertibleLongTermNotesPayable
Total noncurrent liabilities 264,252us-gaap_LiabilitiesNoncurrent 776,451us-gaap_LiabilitiesNoncurrent
Total liabilities 1,861,889us-gaap_Liabilities 16,425,268us-gaap_Liabilities
Commitments and Contingencies (Note 13)      
Stockholders' Deficit    
Common stock, par value $0.001 per share; 500,000,000 shares authorized as of December 31, 2014 and March 31, 2014; 327,739,188 and 224,973,980 shares issued and outstanding as of December 31, 2014 and March 31, 2014, respectively 327,738us-gaap_CommonStockValue 224,984us-gaap_CommonStockValue
Additional paid-in capital 81,632,282us-gaap_AdditionalPaidInCapital 59,659,137us-gaap_AdditionalPaidInCapital
Accumulated deficit (80,743,001)us-gaap_RetainedEarningsAccumulatedDeficit (74,832,557)us-gaap_RetainedEarningsAccumulatedDeficit
Total Aethlon Medical, Inc. stockholders' equity (deficit) before noncontrolling interests 1,217,019us-gaap_StockholdersEquity (14,948,436)us-gaap_StockholdersEquity
Noncontrolling interests 77,587us-gaap_MinorityInterest 218,270us-gaap_MinorityInterest
Total equity (deficit) 1,294,606us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (14,730,166)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilities and deficit $ 3,156,495us-gaap_LiabilitiesAndStockholdersEquity $ 1,695,102us-gaap_LiabilitiesAndStockholdersEquity